Target intelligence / Profile preview

Heat shock protein 90 beta family member 1 (HSP90B1)

Target
HSP90B1
Molecular classification
Molecular chaperone, Heat shock protein (HSP) family, ATPase, Endoplasmic reticulum protein, Other (not a receptor, enzyme, transporter, transcription factor, or ion channel)
01

Overview

Heat shock protein 90 beta family member 1 (HSP90B1), also known as endoplasmin, GRP94, or GP96, is a major ATP-dependent molecular chaperone resident in the endoplasmic reticulum of eukaryotic cells. It is essential for the proper folding, stability, and function of a specific set of client proteins, including integrins, Toll-like receptors, and some secreted and membrane proteins, thereby playing a key role in the unfolded protein response (UPR) and cellular protein homeostasis. HSP90B1 is distinct from cytosolic HSP90 isoforms and is vital for both normal development and immune system function, with links to tumor progression and infectious diseases. While several experimental drugs and immunotherapies target HSP90B1, toxicity remains a challenge for selective inhibition. Its expression is associated with several diseases, including cancer, certain immune disorders, and rare skeletal dysplasias.

Other names
EndoplasminGRP94GP96TRA1Heat shock protein 90kDa beta (Grp94), member 1Heat shock protein 90 kDa beta member 1Heat shock protein family C member 4Tumor rejection antigen (gp96) 194 kDa glucose-regulated proteinTumor rejection antigen 1ERp99
02

Mechanism of action

ATPase inhibition blocks chaperone function—results in misfolding and degradation of client proteins. Modulation of immune chaperoning affects TLR and integrin function. Vaccine mechanism (vitespen): primes adaptive immune response by presenting tumor antigens bound to HSP90B1.

03

Biological functions

Protein foldingRegulation of unfolded protein response (UPR)Stabilization and processing of client proteinsImmune response modulation (folding of Toll-like receptors; integrins)Calcium binding
04

Disease associations

Cancer (onco-chaperone; overexpressed and promoting tumor growth)Immune disorders (essential for immune chaperoning, e.g., for TLRs)Infectious diseases (regulation of pathogen receptor folding)Skeletal dysplasia (Pelizaeus-Merzbacher-Like Disease, Platyspondylic Lethal Skeletal Dysplasia, Torrance Type)GlaucomaMultiple myeloma
05

Safety considerations

Targeting HSP90B1 may disrupt normal protein folding and ER homeostasis, risking toxicity in secretory cells (liver, pancreas, immune cells)Potential immune-related adverse events due to altered immune surveillanceOff-target effects of pan-HSP90 inhibitors on other HSP90 family proteins
06

Interacting drugs

Geldanamycin analogs (e.g., 17-AAG, Alvespimycin; HSP90 inhibitors—research and some clinical candidates)

3 more in the full profile.

07

Biomarkers

HSP90B1/GRP94 protein levels (expression correlates with prognosis in some cancers)Immune checkpoint therapy response (experimental; links to TLRs/immune modulation)ER stress markers (as downstream effect or UPR activation)

Beyond the preview

Go deeper on Heat shock protein 90 beta family member 1 (HSP90B1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Heat shock protein 90 beta family member 1 (HSP90B1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call